Beneficient
	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014	Q1-CY2014	Q4-CY2013
Balance Sheet Date				2025-Mar-31	2024-Dec-31	2024-Sep-30	2024-Jun-30	2024-Mar-31	2023-Dec-31	2023-Sep-30	2023-Jun-30	2023-Mar-31
Fiscal Period				Q4-FY2025	Q3-FY2025	Q2-FY2025	Q1-FY2025	Q4-FY2024	Q3-FY2024	Q2-FY2024	Q1-FY2024	Q4-FY2023
Operating Cash Flow				(8,445,000$)	(9,999,000$)	(8,612,000$)	(10,647,000$)	(8,646,000$)	(22,214,000$)	(13,446,000$)	(13,910,000$)	(21,367,000$)	(13,363,000$)	(23,308,000$)	(37,080,000$)	(11,332,000$)
Investing Cash Flow				10,717,000$	6,224,000$	4,772,000$	6,392,000$	7,320,000$	10,997,000$	14,514,000$	11,226,000$	27,258,000$	16,588,000$	8,599,000$	10,572,000$	11,490,000$
Financing Cash Flow				(5,127,000$)	3,180,000$	3,923,000$	991,000$	(1,965,000$)	20,071,000$	(2,532,000$)	(2,983,000$)	(11,699,000$)	(9,557,000$)	(2,842,000$)	(10,361,000$)	55,626,000$
End Cash Position				1,346,000$	4,149,000$	4,482,000$	4,399,000$	7,913,000$	11,248,000$	2,394,000$	3,057,000$	8,726,000$	15,353,000$	21,685,000$	39,236,000$	70,588,000$
Exchange Rate Effect
Dividends Paid

• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation